1. Selumetinib in patients receiving standard pemetrexed and platinum-based chemotherapy for advanced or metastatic KRAS wildtype or unknown non-squamous non-small cell lung cancer: A randomized, multicenter, phase II study. Canadian Cancer Trials Group (CCTG) IND.219. (July 2019) Authors: Melosky, Barbara; Bradbury, Penelope; Tu, Dongsheng; Florescu, Marie; Reiman, Anthony; Nicholas, Garth; Basappa, Naveen; Rothenstein, Jeffrey; Goffin, John R.; Laurie, Scott A.; Wheatley-Price, Paul; Leighl, Natasha; Goss, Glenwood; Reaume, M. Neil; Butts, Charles; Murray, Nevin; Card, Cynthia; K... Journal: Lung cancer Issue: Volume 133(2019) Page Start: 48 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. HOUT-14. PROGNOSTIC IMPACT OF FIRST PSEUDOPROGRESSION ON MRI IN GLIOBLASTOMA, AN 11 YEARS EXPERIENCE FROM A CANADIAN UNIVERSITY CENTER. (11th November 2019) Authors: Zeidan, Elie; Assad, Anis; Letourneau Guillon, Laurent; Belanger, Karl; Lemieux Blanchard, Emilie; Lemieux, Bernard; Bahary, Jean-Paul; Roberge, David; G Masucci, Laura; Menard, Cynthia; Lambert, Carole; Moumdjian, Robert; Berthelet, France; Ben-Abdallah, Meriem; De Guise, Jacques; Florescu, Marie Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 6 Page Start: vi114 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. HOUT-28. FIRST-LINE TEMOZOLOMIDE VS PCV FOR LOW GRADE GLIOMAS: A 11 YEARS REAL-WORLD DATA FROM CHUM, UNIVERSITY CENTER. (11th November 2019) Authors: Nait Ajjou, Myriam; Assad, Anis; Letourneau Guillon, Laurent; Belanger, Karl; Lemieux Blanchard, Emilie; Lemieux, Bernard; Bahary, Jean-Paul; G Masucci, Laura; Roberge, David; Menard, Cynthia; Lambert, Carole; Moumdjian, Robert; Berthelet, France; Ben-Abdallah, Meriem; De Guise, Jacques; Florescu... Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 6 Page Start: vi118 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. HOUT-23. ADULT MEDULLOBLASTOMA TREATMENT IMPACT SINCE 2006: A CANADIAN UNIVERSITY CENTER EXPERIENCE. (11th November 2019) Authors: Camila Quinones Ninos, Maria; Belanger, Karl; Lemieux Blanchard, Emilie; Lemieux, Bernard; Bahary, Jean-Paul; G Masucci, Laura; Roberge, David; Menard, Cynthia; Lambert, Carole; Moumdjian, Robert; Berthelet, France; Florescu, Marie Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 6 Page Start: vi117 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. A phase I/II study of pembrolizumab in combination with nab-paclitaxel in patients with unresectable stage III or stage IV non small-cell lung carcinoma (NSCLC). (2021) Authors: Nassabein, Rami; Gaudreau, Pierre-Olivier; Belkaid, Wiam; Florescu, Marie; Blais, Normand Journal: Cancer treatment and research communications Issue: Number 28(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 50: Prospective Neurocognitive Functions of Patients Treated with Concurrent Nivolumab and Stereotactic Brain Radiosurgery for NSCLC and RCC Brain Metastases. (October 2021) Authors: Masucci, Giuseppina Laura; Boucher, Olivier; Florescu, Marie; Plourde, Marc-Emile; Ménard, Cynthia; Masson-Côté, Laurence; Panet-Raymond, Valérie; Blais, Normand; Routy, Bertrand; Tehfé, Mustapha; Owen, Scott; Pavic, Michel; Roberge, David; Wong, Philip Journal: Radiotherapy and oncology Issue: Volume 163(2021)Supplement 1 Page Start: S24 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Stereotactic Ablative Radiotherapy for oligo-progressive disease refractory to systemic therapy in Non-Small Cell Lung Cancer: A registry-based phase II randomized trial (SUPPRESS-NSCLC). (March 2022) Authors: Bahig, Houda; Tonneau, Marion; Blais, Normand; Wong, Philip; Filion, Edith; Campeau, Marie-Pierre; Vu, Toni; Al-Saleh, Afnan; Tehfé, Mustapha; Florescu, Marie; Roberge, David; Masucci, Laura; Richard, Corentin; Menard, Cynthia; Routy, Bertrand Journal: Clinical and translational radiation oncology Issue: Volume 33(2022) Page Start: 115 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. BIOS-02. CLINICAL OUTCOMES OF OVER 600 PATIENTS WITH GLIOBLASTOMA TREATED AT A CANADIAN TERTIARY CENTER IN THE PAST 15 YEARS: A COMPARATIVE ANALYSIS WITH THE PIVOTAL STUPP TRIAL. (14th November 2022) Authors: Rousseau, Julien; Desforges, Sara-Maude; Jabbour, Gilbert; Lemieux, Bernard; Lapointe, Sarah; Bélanger, Karl; Moumdjian, Robert; Cayrol, Romain; Florescu, Marie; Masucci, Giuseppina Laura; Berthelet, France; Lemieux-Blanchard, Émilie; Bahary, Jean-Paul Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 7 Page Start: vii20 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Tepotinib Efficacy in a Patient with Non‐Small Cell Lung Cancer with Brain Metastasis Harboring an HLA‐DRB1‐MET Gene Fusion. (8th September 2020) Authors: Blanc‐Durand, Félix; Alameddine, Raafat; Iafrate, Anthony J.; Tran‐Thanh, Danh; Lo, Ying‐Chun; Blais, Normand; Routy, Bertrand; Tehfé, Mustapha; Leduc, Charles; Romeo, Phillipe; Stephenson, Phillipe; Florescu, Marie Journal: Oncologist Issue: Volume 25:Number 11(2020) Page Start: 916 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. QOL-25. IMPACTS OF IMPLEMENTING A PROSPECTIVE TREATMENT AND SURVEILLANCE PROTOCOL FOR THE MANAGEMENT OF NF2-ASSOCIATED VESTIBULAR SCHWANNOMAS ON TUMOR GROWTH, HEARING OUTCOMES, AND QUALITY OF LIFE. (14th November 2022) Authors: Rousseau, Julien; Dahoud, Andrea; Labidi, Moujahed; El Haffaf, Zaki; Florescu, Marie; Saliba, Issam; Gosselin, Marie-Hélène; Lapointe, Sarah Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 7 Page Start: vii246 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗